Global Optical Preclinical Imaging Market – Industry Trends and Forecast to 2029

Optical Preclinical Imaging Market Analysis and Size

The size of the optical preclinical imaging market, which was estimated at USD 419.1 million in 2021, is anticipated to grow from 2022 to 2029. One of the main factors driving the market's growth is the market participants are increased focus on research and development, strategic partnerships, the creation of novel drugs to address unmet medical requirements, and non-invasive diagnostic methods.

Data Bridge Market Research analyses that the optical preclinical imaging market which was USD 419.1 million in 2021, would rocket up to USD 619.20 million by 2029, and is expected to undergo a CAGR of 5.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Optical Preclinical Imaging Market Scope and Segmentation

Market Definition

Live animal research for the development of new drugs uses optical preclinical imaging. The therapy response is also tracked for early signs of efficacy using optical preclinical imaging. The ability to quantitatively examine disease at the molecular level is made possible by technological advancements in in vivo imaging. The direct and quick transition from preclinical study using animal models to clinical investigation in people is made possible by in vivo imaging, which links in vitro exploratory and in vivo clinical research.

Optical Preclinical Imaging Market Dynamics

Drivers

• Technological developments

Increasing market demand for non-invasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, technological advancements in the field of molecular imaging are some of the factors that will likely to enhance the growth of the optical preclinical imaging market in the forecast period of 2022 to 2029. 

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of optical preclinical imaging market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.

Opportunities

The growth of the optical preclinical imaging market is fuelled by developing markets to offer new growth opportunities. This will provide beneficial opportunities for the optical preclinical imaging market growth.

Moreover, rise in the number of emerging markets and new product launches will further provide beneficial opportunities for the optical preclinical imaging market growth during the forecast period.

Restraints/Challenges

• High cost for installation and stringent regulations for preclinical research

On the other hand, the stringent regulations governing preclinical research will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the meningococcal disease vaccine market.

Technological and procedural limits associated with standalone preclinical imaging systems will also challenge market growth.

This optical preclinical imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the optical preclinical imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Optical Preclinical Imaging Market

In addition, the COVID-19 pandemic forced a massive restructuring of clinics and hospitals around the world to increase the hospital capacity for COVID-19 patients. Due to the exponentially increasing COVID-19 instances, non-essential treatments could potentially be delayed. In contrast, several preclinical research projects and initiatives by different researchers, businesses, and the government including clinical trials for the efficacy and safety for the treatment of COVID-19 boosted the development of the optical preclinical imaging industry.

Recent Development

• In 2019, the first ultra-high resolution E class system was installed for preclinical imaging in Japan at Kawasaki Medical University, a research hub for cutting-edge medical services and technology in Yokahama.

Global Optical Preclinical Imaging Market Scope

The optical preclinical imaging market is segmented on the basis of product type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Device
• Fluorescence
• Bioluminescence
• Consumables
• Fluorescence
• Green fluorescent proteins
• Red fluorescent proteins
• Infrared dyes
• Others
• Bioluminescence
• Luciferins
• Proluciferins
• Coelenterazine
• Others
• Software

End-use

• Pharma and Biotech Companies
• Research Institutes
• Others

Optical Preclinical Imaging Market Regional Analysis/Insights

The optical preclinical imaging market is analysed and market size insights and trends are provided by country, product type and end-user as referenced above.

The countries covered in the optical preclinical imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the optical preclinical imaging market due to the rising prevalence of chronic diseases such as cardiovascular disease, cancer and others in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to well-established medicine manufacturing sector and the presence of the world’s most prominent research laboratories and research-oriented universities. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The optical preclinical imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for optical preclinical imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the optical preclinical imaging market. The data is available for historic period 2010-2020.

Competitive Landscape and Optical Preclinical Imaging Market Share Analysis

The optical preclinical imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to optical preclinical imaging market.

Some of the major players operating in the optical preclinical imaging market are:

• Arthrex Inc. (Germany)
• Johnson & Johnson Services, Inc. (U.S.)
• NuVasive Inc. (U.S.)
• Orthofix US LLC (U.S.)
• Pega Medical Inc. (Canada)
• Smith+Nephew (U.K.)
• Stryker (U.S.)
• WishBone Medical (U.S.)
• Zimmer Biomet (U.S.)
• Medtronic (Ireland)
• Auxein Medical (India)
• Implanet SA (U.S.)
• Merete GmbH (Germany)
• Mighty Oak Medical (U.S.)

SKU-54389